Sodium Bicarbonate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Exela Pharma Sciences, LLC with status Current. The shortage was first posted on 07/24/2017.
Shortage Details
- Status
- Current
- Company
- Exela Pharma Sciences, LLC
- Package NDC
- 51754-5011-4
- Dosage Form
- Injection
- Presentation
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)
- Initial Posting
- 07/24/2017
- Revised Date